Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Journal of Cancer|April 21, 2018
Increased AURKA Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral MelanomaJunya Yan, Jiayi Yu, Xiaowen Wu, et al.
Cancer Science|April 17, 2018
High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosisTianxiao Xu, Meng Ma, Zhihong Chi, et al.
Oncology Letters|February 14, 2018
Clinical significance of BRAFV600E mutation in circulating tumor DNA in Chinese patients with melanomaHuan Tang, Yan Kong, Lu Si, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 21, 2025
MARCO+ Tumor-Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell CarcinomaJiayuan Chen, Jiazhi Mo, Jinchang Wei, et al.
Urologic Oncology|June 30, 2022
Clinicopathological characteristics and prognosis of metastatic collecting duct carcinomaLi Zhou, Yiqiang Liu, Jiazhi Mo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 24, 2019
miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapyHuan Tang, Meng Ma, Jie Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 CasesXue Bai, Yan Kong, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2016
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosisXinan Sheng, Yan Kong, Yiqian Li, et al.
Translational Oncology|July 30, 2018
Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment FailureChuanLiang Cui, Li Zhou, Bin Lian, et al.
Frontiers in Pharmacology|December 3, 2021
Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical StudiesHui Tian, Xuan Wang, Bin Lian, et al.
Pageof 13